Clinical Trials Directory

Trials / Completed

CompletedNCT03497325

Effect of Autologous Platelet-rich Plasma in Uterine Wound Healing

the Efficacy of Intramuscular Autologous Platelet-rich Plasma Injection on Uterine Wound Healing After Primary Cesarean Section

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
134 (actual)
Sponsor
Ain Shams University · Academic / Other
Sex
Female
Age
18 Years – 35 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to evaluate the efficacy of intramuscular autologus platelet rich plasma on uterine wound healing after primary cesarean section

Detailed description

110 pregnant female undergoing primary prelabor CS will be randomized to two groups group A)autologus PRP will be prepared from participant venous blood collected from the participants' arm into a syringe primed with ACD-A. then it will be injected into uterus after closing uterine incision . Injection sites will be selected near the incision at evenly 20 different sites group B)normal saline 0.9 will be injected into uterus after closing uterine incision . Injection sites will be selected near the incision at evenly 20 different sites.

Conditions

Interventions

TypeNameDescription
DRUGautologus platelet rich plasma55 participant unergoing prelabor primary CS will receive intramyometrial injection of PRP after closure of uterine incision
DRUGplacebo55 participant unergoing prelabor primary CS will receive intramyometrial injection of normal saline after closure of uterine incision

Timeline

Start date
2020-02-01
Primary completion
2020-12-15
Completion
2020-12-15
First posted
2018-04-13
Last updated
2021-07-21

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT03497325. Inclusion in this directory is not an endorsement.